Moderna execs spent millions on luxury homes due to COVID vaccine sales – OutKick
There have been few better jobs in recent years than being an executive at Moderna or Pfizer.
A new report from the Daily Mail details Moderna’s incredible financial success resulting from the sale of millions of doses of mRNA vaccines to governments around the world.
Of course, the vaccine’s effectiveness wanes rapidly, necessitating booster shots, which in turn further enrich Moderna’s leadership. And of course, initial estimates of vaccine effectiveness were grossly overestimated, because even Deborah Birx now admits.
Even the boosters that experts and media tell us about are an indisputable necessity, only about 20% effective, according to new research:
But none of that has stopped Moderna from racking up record profits after never delivering a single pre-COVID vaccine.
The biggest financial beneficiaries of this incredible rise to wealth have been Moderna employees, who apparently engaged in a real estate war in Boston with other wealthy pharmaceutical company executives.
Competition for multimillion-dollar luxury real estate has become so fierce that, according to the report, a high-ranking, unnamed Moderna employee specifically demanded to be one floor higher than the competition at Pfizer:
“An anonymous Moderna executive made an offer to buy a 17th-floor unit in the St. Regis building overlooking Boston Harbor for $4.9 million the same day a Pfizer executive bought a condo in the same building on the 16th floor for $4.8 million. .
The building’s sales manager, Cathy Angelini, told the Journal that the Moderna executive told her he wanted his house to be one story higher than the Pfizer executive. She said: “He just looked at me, completely serious and said, ‘I want the same house, but I have to be one floor higher than Pfizer. “”
The aforementioned Moderna executive was described as not being “concerned about the price”.
It certainly pays to have a product that needs to be updated every six months with desperate and panicked world governments as its main customer.
It must be nice.
The executive paying in the $4.9m range was only expected to be a vice president or lower, given that the company’s ‘human resources director’ bought a house for $6m in April 2021.
There are many other examples spreading in New York and elsewhere.
The business could also have benefited those leaders had politicians, universities and corporations mandate vaccines as a condition of employment or attendance, despite overwhelming evidence that they did not prevent infection or transmission.
Even now, New Zealand is close to the highest current death rate in the world with exceptionally high vaccination coverage:
So sure, Moderna has overpromised and underdelivered while turning its business model into an endless, indefinite profit machine, but at least their top executives will be able to relax in their mansions after another hard day of 8th booster development with 20% efficiency.